Skip to Main Content
Colorado Attorney General

Phil Weiser

Colorado Attorney General

File A Complaint
  • About Us
    • Attorney General Bio & Photos
    • Vision & Values
    • Senior Staff & Organization
    • Colorado Attorney General Annual Report
    • Attorney General Opinions
    • Budget & Accounting
    • Contact Our Office
  • Sections
    • Administration
    • Civil Litigation & Employment Law
    • Consumer Protection
    • Criminal Appeals
    • Criminal Justice
    • Natural Resources & Environment
    • Division of Community Engagement
    • Revenue & Regulatory Law
    • State Services
  • Careers
    • Attorney & Other Non-Classified Positions
    • Fellowships
    • Internships
    • Classified Staff Positions
    • Other Opportunities to Join our Team
  • Media Center
    • Press Room
    • Colorado Open Records Act – CORA
  • Resources
    • Survivors of Childhood Sexual Abuse
    • Victim Assistance
    • Colorado Privacy Act
    • Data Protection Laws
    • Extreme Risk Protection Order (ERPO) Trainings and Resources
    • Funding Opportunities
    • Office of Financial Empowerment
    • Code of Colorado Regulations
    • Colorado Revised Statutes
    • Transparency Online Project (TOPS)
  • Licensing
    • Business Resources
    • Collection Agencies & Debt Collectors
    • Credit Services Organizations
    • UCCC Licensing & Notification
    • Debt Management Services Providers
    • Health Club Bonds
    • Repossessors
    • Student Loan Servicer Licensing
    • Telemarketing
  • Recursos en español

Attorney General Phil Weiser announces $102.5 million settlement with Suboxone maker for alleged illegal monopoly tactics

June 2, 2023 (DENVER) –Attorney General Phil Weiser announced that 42 states have negotiated a nationwide $102.5 million settlement with Indivior Inc., the maker of Suboxone. Colorado will receive approximately $2.5 million from the settlement. 

“As communities throughout Colorado were being devastated by the opioid crisis, Invidior was taking advantage of the crisis and scheming to limit competition and increase profits for Suboxone, a drug that is used to treat opioid addiction. The Department of Law is committed to holding drug manufacturers accountable when they break the law by maintaining an illegal monopoly over important life-saving treatments,” Attorney General Phil Weiser said. 

Suboxone is a drug approved for use by people with opioid addiction to avoid or reduce withdrawal symptoms while they undergo treatment. The medication previously came in tablet form, but in 2010, its manufacturer, Indivior Inc., switched from tablet to film, citing safety concerns. In 2016, the States filed a complaint against Indivior alleging that this switch from tablet to film was anticompetitive and designed to maintain Indivior’s market monopoly and thwart the entry of a generic equivalent into the market, a scheme known as “product hopping.” Trial had been set for September 2023. 

The agreement, which will be submitted to the federal court in the Eastern District of Pennsylvania for approval, requires Indivior to pay the states $102.5 million. Indivior is also required to comply with negotiated injunctive terms that include disclosures to the States of all citizen petitions to the U.S. Food and Drug Administration, introduction of new products, or if there is a change in corporate control, which will help the States ensure that Indivior refrains from engaging in the same kind of conduct alleged in the complaint.  

Others joining the settlement includes the attorneys general from Alabama, Alaska, Arkansas, California,  District of Columbia, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin. 

###

Media Contact:
Lawrence Pacheco
Chief Communications Officer
(720) 508-6553 office | (720) 245-4689 cell
lawrence.pacheco@coag.gov

Most Recent

Colorado attorney general logo against mountain peaks background and text that reads News from Attorney General Phil Weiser

Attorney General Phil Weiser vows to defend Colorado's common-sense gun safety law from Trump DOJ attack

May 6, 2026 (DENVER) — Attorney General Phil Weiser released the following statement regarding the Trump Justice Department’s new lawsuit challenging Colorado’s common-sense large-capacity magazine limit law: “Using federal civil rights law to put Coloradans at greater risk of gun […]

Colorado attorney general logo against mountain peaks background and text that reads News from Attorney General Phil Weiser

Colorado awards $11 million for opioid treatment and recovery in most competitive funding round to date

May 5, 2026 (DENVER) – The Colorado Opioid Abatement Council has awarded $11 million to 24 organizations and local governments in its most competitive infrastructure funding round to date, expanding opioid treatment, recovery, and prevention services across the state. The […]

Colorado attorney general logo against mountain peaks background and text that reads News from Attorney General Phil Weiser

Attorney General Phil Weiser files brief urging Supreme Court to stay restrictions on mifepristone

May 4, 2026 (DENVER) — Attorney General Phil Weiser today joined a coalition of 22 states and the District of Columbia in urging the U.S. Supreme Court to stay a ruling by the U.S. Court of Appeals for the Fifth […]

Office of the Attorney General
Colorado Department of Law
Ralph L. Carr Judicial Building
1300 Broadway, 10th Floor
Denver, CO 80203

(720) 508-6000

Contact the Office of the Attorney General

Contact

ACCESSIBILITY STATEMENT

DECLARACION DE ACCESIBILIDAD

Facebook
Twitter
LinkedIn
Instagram
YouTube
BlueSky

Attorney General Phil Weiser is working to defend Colorado communities against harmful and illegal actions from the federal government.

Learn more: Defending Colorado